Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids

Neuro-oncology Practice
Christa P Bénit, Charles J Vecht

Abstract

Patients with cancer commonly experience seizures. Combined therapy with anticonvulsant drugs (AEDs) and chemotherapeutic drugs or tyrosine kinase inhibitors carries inherent risks on drug-drug interactions (DDIs). In this review, pharmacokinetic studies of AEDs with chemotherapeutic drugs, tyrosine kinase inhibitors, and glucocorticoids are discussed, including data on maximum tolerated dose, drug clearance, elimination half-life, and organ exposure. Enzyme-inducing AEDs (EIAEDs) cause about a 2-fold to 3-fold faster clearance of concurrent chemotherapeutic drugs metabolized along the same pathway, including cyclophosphamide, irinotecan, paclitaxel, and teniposide, and up to 4-fold faster clearance with the tyrosine kinase inhibitors crizotinib, dasatinib, imatinib, and lapatinib. The use of tyrosine kinase inhibitors, particularly imatinib and crizotinib, may lead to enzyme inhibition of concurrent therapy. Many of the newer generation AEDs do not induce or inhibit drug metabolism, but they can alter enzyme activity by other drugs including AEDs, chemotherapeutics and tyrosine kinase inhibitors. Glucocorticoids can both induce and undergo metabolic change. Quantitative data on changes in drug metabolism help to apply the appr...Continue Reading

References

Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D K BakerJ H Rodman
Nov 1, 1989·The American Journal of Medicine·S A GrossmanM R Gilbert
Apr 1, 1988·Clinical Pharmacology and Therapeutics·C Neef, I de Voogd-van der Straaten
Jan 1, 1987·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·M Bartoszek, S J Szefler
Oct 18, 1985·JAMA : the Journal of the American Medical Association·D D WongM LaVergne
Oct 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·J B ChalkM J Eadie
Jul 1, 1994·Pediatric Hematology and Oncology·H Schrøder, J R Ostergaard
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J H RodmanV M Santana
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K MrossD K Hossfeld
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·M HassanM Lindgren
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J T SlatteryF R Appelbaum
Sep 19, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R FetellS Piantadosi
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M ChangM D Prados
Nov 4, 2000·Clinical Pharmacology and Therapeutics·J S McCuneC Lindley
Apr 13, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V BourgM Frenay
Apr 30, 2002·The Annals of Pharmacotherapy·Hiroki KonishiAkira Yamaji
Jul 10, 2003·Lancet Neurology·Charles J VechtErik B Wilms
Aug 14, 2003·British Journal of Cancer·K BrickellP Thompson
Feb 3, 2005·Cancer Chemotherapy and Pharmacology·Milly E de JongeSjoerd Rodenhuis
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisUNKNOWN North Central Cancer Treatment Group
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy F CloughesyMichael Prados
Oct 20, 2005·Clinical Pharmacokinetics·Milly E de JongeJos H Beijnen
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David A ReardonJeremy N Rich
Mar 15, 2006·Neuro-oncology·Michael D PradosUNKNOWN North American Brain Tumor Consortium
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R SoffiettiC Vecht
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick Y WenMichael D Prados
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stuart A GrossmanJeffrey G Supko
Oct 20, 2006·Clinical Pharmacokinetics·Svein I Johannessen, Torbjörn Tomson
Apr 17, 2007·Lancet Neurology·Melanie S M van BreemenCharles J Vecht
Apr 19, 2007·Journal of the National Cancer Institute·Rachel P RiechelmannMonika K Krzyzanowska
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica E LoghinW K Alfred Yung
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John G KuhnUNKNOWN North American Brain Tumor Consortium and the National Cancer Institute
Apr 26, 2008·Cancer Chemotherapy and Pharmacology·Corine EkhartAlwin D R Huitema

❮ Previous
Next ❯

Citations

Jun 2, 2020·CA: a Cancer Journal for Clinicians·Aaron C TanMustafa Khasraw
Mar 12, 2016·Nature Reviews. Neurology·Gilles Huberfeld, Charles J Vecht
Feb 9, 2020·Current Treatment Options in Neurology·Roberta RudàAlessia Pellerino
Jan 7, 2020·Anesthesiology and Pain Medicine·Washington Aspilicueta Pinto FilhoJosenilia Alves Gomes
Sep 16, 2020·Cellular and Molecular Neurobiology·Giuditta GambinoPierangelo Sardo
May 12, 2017·Journal of Neuro-oncology·Charles VechtGilles Huberfeld
Jun 6, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·B Cacho-DiazN Lorenzana-Mendoza
Feb 2, 2021·Frontiers in Oncology·Gan YouTao Jiang
Nov 10, 2020·Cancer Letters·Tao JiangUNKNOWN Asian Glioma Genome Atlas (AGGA) network
Jun 19, 2021·Epilepsy & Behavior Reports·Ajith CherianHarini Pavuluri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.